Antenatal screening providers should be developing plans to replace the national printed family origin questionnaire from spring 2021 onwards.
Amanda was appointed national programme manager of the NHS Sickle Cell and Thalassaemia Screening Programme in July 2019. She brings knowledge and experience from midwifery, midwifery supervision and public health and is passionate about providing high-quality care for women, babies and their families. Amanda’s previous roles have included being a senior quality assurance advisor in the Midlands and East region, a head of midwifery and associate nurse director, matron, birth centre and community team manager. She is a professional midwifery advocate jointly providing expert advice on professional nursing and midwifery subjects within PHE as part of the Nursing and Midwifery Revalidation Group.
This blog article gives providers guidance on sickle cell and thalassaemia screening for women who are pregnant via egg donation.
Related content and links
The PHE Screening team
Public Health England (PHE) existed to protect and improve the nation’s health and wellbeing, and reduce health inequalities. It closed on 30 September 2021 and this blog is no longer updated.
Find out more about the implications for health screening in our Changes ahead for the national screening system blog article.
If you want to stay in touch with screening evidence and policy news, you can subscribe to the UK National Screening Committee blog.
Comments and moderation
- Changes ahead for the national screening system 30 September 2021
- What we blogged about in August and September 2021 30 September 2021
- New resources to help improve quality of samples taken in NHS newborn blood spot screening 30 September 2021